HUMAN EMBRYONIC STEM CELL,HUMAN,EMBRYONIC,STEMCELLS,DEPARTMENT OF HEALTH HUMAN,SEARCH,TIPS,INFO,RESEARCH,TOPICS,FEDERAL,POLICY,GLOSSARY,STEM CELL,INFORMATION,GENERAL,CLINICAL TRIALS,FUNDING,CURRENT,RESEARCH POLICY,SITE MAP,JUMP,NAVIGATION,YOU ARE,NEW ERA,STEM CELL BIOLOGY,DERIVATION,CELLS,BLASTOCYSTS,FETAL,TISSUE,UNIQUE,ABILITY,THE BODY,THE CELLS,PLURIPOTENT,MOLECULAR,ADDITION,SCIENTISTS,BEGINNING,DIRECT,DIFFERENTIATION OF,PLURIPOTENT STEM CELLS,FUNCTIONAL,SPECIALIZED CELLS,PHASES,PROVING,INNOVATIVE,CELL,STRATEGIES,CRITICAL,FUNCTIONS,DISEASED,DAMAGED,HUMAN BODY,OVERVIEW,JAMES THOMSON,COLLEAGUES,REPORTED,MAINTAINING,EMBRYONIC STEM,ES CELLS,INNER CELL MASS,IN VITRO FERTILIZATION,DONATED,SAME TIME,GROUP,BY JOHN,IDENTIFIED,GERM,CULTURED,PRIMORDIAL GERM CELLS,GONADAL RIDGE,MESENCHYMA,OF 5,WEEK,ELECTIVE,ABORTIONS,DEVELOPED,DRAWING,HOST,ANIMAL STUDIES,DATE,ALMOST,40 YEARS,MOUSE,REPORTS,EXPERIMENTS,STEM CELLS,DERIVED,CULTURE,RHESUS MONKEYS,MARMOSETS,CLINICS,PREPARE,HUMAN EMBRYOS,TRANSPLANTING,UTERUS,PRODUCE,LIVE BIRTH,TIMELINE OF,ATTEMPTS,FERTILIZE,MAMMALIAN,EGGS,OUTSIDE,FIRST REPORT,ANIMALS,RABBITS,THE UNITED STATES,1960S,TESTES,INBRED,STRAINS,OF MICE,EMBRYONIC GERM CELLS,THE WORK,EMBRYONAL CARCINOMA,KIND,DISCUSSION,APPENDIX,C,EDWARDS,THE FIRST HUMAN,EGG,IN VITRO,1970S,MICE,EMBRYONIC DEVELOPMENT,COMPLEMENT,ABNORMAL,LOUISE BROWN,BABY,ENGLAND,AUSTRALIAS,CANDACE,REED,MELBOURNE,EVANS,KAUFMAN,MARTIN,DERIVE,CONDITIONS,YIELD,CELL LINES,NORMAL,DIPLOID,PRIMARY,GERM LAYERS,INDUCES,THE FORMATION OF,TERATOMAS,ELIZABETH CARR,ANDREWS,DEVELOP,GENETICALLY,IDENTICAL,CLONAL,TERA,CELL LINE,TESTICULAR,CLONED,TERATOMA,EXPOSED,RETINOIC ACID,DIFFERENTIATE,NEURON,PERA,YIELDS,ANEUPLOID,FEWER,GREATER THAN,THE NORMAL,NUMBER,THE CELL,POTENTIAL,LIMITED,BEHAVIOR,EC CELL,CLONES,REPRODUCTIVE,PATIENTS,THE 2,PRONUCLEAR,STAGE,BLASTOCYST,TROPHOBLAST,THE PERIPHERY,THE CENTER,RETAIN,COMPLETE,KARYOTYPE,CULTURES,MORPHOLOGY,FIBROBLASTS,PASSAGES,NON HUMAN PRIMATE,PRIMATE,KARYOTYPES,SHOULD,POSSIBLE,THOMSON,COUPLES,INFERTILITY,HIGH,TELOMERASE,ACTIVITY,EXPRESS,PANEL,IMMUNE,PLURIPOTENCY,GROW,THE EXPRESSION,DO NOT,SINGAPORE,AUSTRALIA,PERIODS,SOMATIC CELL,UMAN,ES CELL,LINES,NEW LINES,REPORT,TRANSPLANTATION,PANCREATIC ISLET,RELEASE,DOPAMINE,CARDIAC MUSCLE CELLS,HUMAN EMBRYONIC STEM CELLS,DOCUMENTATION,ISOLATION,EMBRYONIC STEM CELLS,TECHNIQUES,REFINED,ISOLATE,SEEMS,DEPEND,INTEGRITY,CONDITION,DISTINCT,FIGURE,SHOWING,TROPHECTODERM,PHOTO,CREDIT,MR J,OOCYTE,FERTILIZED,SPERM CELL,EVENTS,TIMELINE,24 HOURS,DAY 1,HOURS,ZYGOTE,CLEAVAGE,EMBRYO,72 HOURS,MORULA,GENOME,BEGINS,CONTROL,DEVELOPMENT,MEANS,MATERNAL,PRESENCE,MRNA,PROTEINS,CYTOPLASM,REDUCED,TO EACH,PROCESS,COMPACTION,DAY 5,OUTER,OBSERVABLE,SIGN,CELL DIFFERENTIATION,TRANSFER,EMBRYOS,OPTIMAL,IMPLANTATION,PARALLELS,THE STAGE,IMPLANT,THE WALL,IN VIVO,CHANGE,IMPLANTATION RATE,USED TO,HUMAN EMBRYO,MICROSURGERY,IMMUNOSURGERY,ANTIBODIES,HELP,BREAK IT DOWN,THUS,ELSEWHERE,ONCE,THE TECHNIQUES,SIMILAR,SHARE,FETUS,NORMALLY,MATURE,GAMETES,SPERM,COLLABORATORS,THE PROCESS,GENERATION,BODIES,DIFFERENTIATED CELL,EMBRYOID BODY,PROLIFERATIVE,CAPACITY,GENE EXPRESSION PATTERNS,REPRESENTATIVE OF,MULTIPLE,SUGGESTS,PROGENITOR,PRECURSOR CELLS,VARIETY,DESCRIPTION,TRULY,PLURIPOTENT STEM CELL,SELF,RENEWAL,LONG TERM,POPULATION,LESS,PROLIFERATION,MAXIMUM,LABORATORIES,THE ONLY,EPITHELIUM,ENDODERM,SMOOTH,STRIATED MUSCLE,NEURAL,STRATIFIED SQUAMOUS EPITHELIUM,ECTODERM,EVIDENCE,ORGANISM,MADE UP,GENETIC,GERM CELLS,THE PRECURSORS,THEORETICAL,CONDUCTED,CASE,THERAPEUTIC,USES,DRUG DEVELOPMENT,EXAMPLE,COMPARISONS BETWEEN,CASES,REPLICATE,PERIOD OF TIME,SHOW,CHROMOSOMAL ABNORMALITIES,XX FEMALE,XY MALE,CHARACTERISTIC,THE CULTURE,PERMIT,DIFFERENTIATION,BELOW,DETAILS,TABLE,COMPARISON,MONKEY,THE TISSUE,SOURCES,WITH RESPECT TO,PROPAGATED,HUNDRED,FOR ONLY,IMMUNOCOMPROMISED,COLONIES,TRYING TO GROW,FEEDER,LAYERS,LABOR,INTENSIVE,RECENT,MEETING,GERON CORPORATION,MEDIUM,DIRECTED DIFFERENTIATION,MAJOR,GOAL,EMBRYONIC STEM CELL RESEARCH,OBJECTIVE,MUST,ARE TO,BASIS,TESTING,DRUGS,SCREENING,TOXINS,TESTED,MARKER,NAME,EMBRYONIC STEM CELL,EMBRYONIC GERM CELL,STAGE SPECIFIC EMBRYONIC,ANTIGEN,TUMOR,REJECTION,LEUKEMIA INHIBITORY FACTOR,BFGF,BASIC FIBROBLAST GROWTH FACTOR,SSEA 3,ALKALINE PHOSPHATASE,OCT 4,UNKNOWN,UNKNOWN UNKNOWN,FEEDER CELL,DEPENDENT,YES YES YES,EFFICIENCY,FACTORS,GP130,RECEPTOR,SUBSTITUTE,LAYER,CO CULTURE,SERUM,FREE,FORSKOLIN,MULTI LAYER,FLAT,LOOSE,FORMATION,CHIMERA,DISCUSSED,TRANSPLANT,THERAPY,REPLACE,DISEASE,INJURY,CHAPTERS,DISEASES,MIGHT BE,PARKINSONS DISEASE,DIABETES,SPINAL CORD INJURY,PURKINJE CELL,DEGENERATION,DUCHENNES MUSCULAR DYSTROPHY,HEART FAILURE,OSTEOGENESIS IMPERFECTA,FOR ANY,PRIOR,THE RESEARCH,ACCESS,THERAPIES,EXPERIMENTAL,DEVELOPMENT OF,PERMISSION,THE CURRENT,ADVANTAGES,ADULT STEM CELLS,UNLIMITED,ABLE,BROAD,RANGE,NECESSARY,SURVIVE,INTEGRATE,FUNCTION,THE POTENTIAL,DISADVANTAGES OF,PROPENSITY,INDUCE,TUMORS,BENIGN,RATHER,PROGENY,FAIL SAFE,MECHANISM,INSERT,SUICIDE,GENES,TRIGGER,DEATH,TUMORIGENIC,ADVANTAGEOUS,IMMUNE REJECTION,IMMUNOLOGICAL,STATUS,DETAIL,I